Importance The incidence and prevalence of neuroendocrine tumors (NETs) are thought to
be rising, but updated epidemiologic data are lacking. Objective To explore the evolving
epidemiology and investigate the effect of therapeutic advances on survival of patients with
NETs. Design, Setting, and Participants A retrospective, population-based study using
nationally representative data from the Surveillance, Epidemiology, and End Results (SEER)
program was conducted to evaluate 64 971 patients with NETs from 1973 to 2012 …